I think it needs to be faster, and we need to make sure we're continuing to have access to new medications.
I heard the same concern about the medical devices special access program, especially the regulatory burden this will put on smaller entrepreneurs that are introducing medical devices into Canada. It might limit the number of new devices we would see. Could you comment on how you might be able to change that process to not put such a regulatory burden on small companies?